WHO South-East Asia urges to plan for effective roll-out of Covid vaccine

World Health Organization has called for stronger collective efforts to curtail the virus transmission, urging the countries to plan for efficient roll out of vaccines as soon as they are available.

WHO South-East Asia urges to plan for effective roll-out of Covid vaccine
Press Trust of India New Delhi
2 min read Last Updated : Oct 08 2020 | 7:27 PM IST

As COVID-19 continues to spread in most countries of the WHO South-East Asia Region, the World Health Organization has called for stronger collective efforts to curtail the virus transmission, urging the countries to plan for efficient roll out of vaccines as soon as they are available.

"Like the rest of the world, the region continues to be at risk. To stop the spread of COVID-19 virus, we need to do it all continued strong leadership, robust public health measures, clear communication and an engaged, empowered and enabled population," said Dr Poonam Khetrapal Singh, Regional Director, WHO South-East Asia Region.

In a communication to member countries, the regional director said the global race for a COVID-19 vaccine has gathered momentum.

In anticipation of development of a safe and effective COVID-19 vaccine, countries should be prepared with an efficient and coordinated strategy and plan for roll-out of vaccination, she said.

Vaccine availability is likely to be limited initially, hence will be important to clearly identify goals of national vaccination strategy, Singh added.

In the spirit of promoting fair and equitable access to the vaccines across all countries, WHO is proposing that countries prioritise at-risk population as they develop in-country vaccination strategies. Available vaccines should first be provided to priority populations and then expanded to others, she said.

"The COVID-19 vaccination should aim at minimising the societal and economic impact by reducing deaths caused by the disease," Singh said.

Listing out nine priority areas for COVID-19 vaccine introduction and roll-out, the regional director said, a national level coordination committee would be needed to oversee vaccination; an expedited regulatory pathway for approval of new vaccine; a technical advisory group to recommend prioritisation of risk groups; protocols on infection prevention and control measures to minimise exposure during immunisation sessions; training plans for vaccine introduction; and monitoring systems to measure coverage, acceptability and disease surveillance.

Countries would also need to strengthen vaccine cold chain systems, ensure trained staff perform vigilance activities for vaccine safety and importantly, a vaccine demand generation plan to instill confidence and acceptance among people for the new vaccine.

Ensuring continued WHO support, Sigh said, "Together we must continue to strengthen the COVID-19 response by aggressively applying the basic public health measures, and also looking ahead and ensuring that we make full use of emerging tools to control spread, save lives and minimise impact.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Coronavirus VaccineWHO

First Published: Oct 08 2020 | 7:13 PM IST

Next Story